The Expression of Inflammatory Mediators in Bladder Pain Syndrome.
dc.contributor.author | Offiah, Ifeoma | |
dc.contributor.author | Didangelos, Athanasios | |
dc.contributor.author | Dawes, John | |
dc.contributor.author | Cartwright, Rufus | |
dc.contributor.author | Khullar, Vik | |
dc.contributor.author | Bradbury, Elizabeth J | |
dc.contributor.author | O'Sullivan, Suzanne | |
dc.contributor.author | Williams, Dic | |
dc.contributor.author | Chessell, Iain P | |
dc.contributor.author | Pallas, Kenny | |
dc.contributor.author | Graham, Gerry | |
dc.contributor.author | O'Reilly, Barry A | |
dc.contributor.author | McMahon, Stephen B | |
dc.date.accessioned | 2018-01-22T12:05:38Z | |
dc.date.available | 2018-01-22T12:05:38Z | |
dc.date.issued | 2016-08 | |
dc.identifier.citation | The Expression of Inflammatory Mediators in Bladder Pain Syndrome. 2016, 70 (2):283-90 Eur. Urol. | en |
dc.identifier.issn | 1873-7560 | |
dc.identifier.pmid | 26965559 | |
dc.identifier.doi | 10.1016/j.eururo.2016.02.058 | |
dc.identifier.uri | http://hdl.handle.net/10147/622749 | |
dc.description.abstract | Bladder pain syndrome (BPS) pathology is poorly understood. Treatment strategies are empirical, with limited efficacy, and affected patients have diminished quality of life. | |
dc.language.iso | en | en |
dc.publisher | European urology | en |
dc.relation.url | http://www.sciencedirect.com/science/article/pii/S0302283816002487?via%3Dihub | en |
dc.rights | Archived with thanks to European urology | en |
dc.subject | BLADDER | en |
dc.subject | PAIN | en |
dc.subject.mesh | Adult | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Chemokine CCL21 | |
dc.subject.mesh | Cystitis, Interstitial | |
dc.subject.mesh | Disease Models, Animal | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fibroblast Growth Factor 7 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Inflammation Mediators | |
dc.subject.mesh | Pain | |
dc.subject.mesh | Rats | |
dc.subject.mesh | Signal Transduction | |
dc.subject.mesh | Statistics as Topic | |
dc.subject.mesh | Symptom Assessment | |
dc.subject.mesh | Urinary Bladder | |
dc.subject.other | UROLOGY | en |
dc.subject.other | TREATMENT STRATEGIES | en |
dc.title | The Expression of Inflammatory Mediators in Bladder Pain Syndrome. | en |
dc.type | Article | en |
dc.identifier.journal | European urology | en |
dc.description.funding | No funding | en |
dc.description.province | Munster | en |
dc.description.peer-review | peer-review | en |
refterms.dateFOA | 2018-08-28T01:10:19Z | |
html.description.abstract | Bladder pain syndrome (BPS) pathology is poorly understood. Treatment strategies are empirical, with limited efficacy, and affected patients have diminished quality of life. |